Dopaminergic imaging and clinical features predict phenoconversion of sleep behavior disorder


  • Older people with idiopathic REM sleep behavior disorder, with constipation and reduced nigro-putaminal dopaminergic function, are at high risk of phenoconversion to overt synucleinopathy.

Why this matters

  • Neuroprotective treatments in the early stages of synucleinopathies are key to rescuing brain structure and function. However, their effectiveness in early disease can be hindered by the inability to identify those with prodromal neurodegenerative disease.

  • Dopamine transporter single photon emission tomography is a novel tool that could help to stratify participants in neuroprotective clinical trials and ultimately improve long-term treatment outcomes.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.